Zydus Sees Revlimid Generic Revenues Beyond Q4 As It Waits For Antitrust Suit To Play Out

Acquires Teva Group API Maker Watson

 
• By Vibha Ravi
Growth Story
Zydus Is Planning For Growth, But Will Generic Revlimid Cast A Shadow • Source: Shutterstock

More from Business

More from Scrip